Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.

This study has been completed.
Information provided by:
Tibotec Pharmaceuticals, Ireland Identifier:
First received: August 29, 2008
Last updated: April 26, 2010
Last verified: April 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):